Welcome to Beyond the Drip, where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired.
As the year comes to a close, Beyond the Drip delivers a forward-looking conversation on the evolving infusion and specialty pharmacy landscape. In the final episode of the year, our co-hosts sit down with Vic Simianu, CEO and Founder of Sphinx Strategies, to discuss his path into infusion, the mounting pressures on independent pharmacies and what the next three to five years will require from industry leaders.
With a background in biotech, finance and early-stage startups, Vic entered specialty pharmacy just as it was emerging as a $60 billion industry, which is now a trillion-dollar market. That experience shaped his decision to launch Sphinx Strategies, recognizing that independent pharmacies needed a way to stay competitive without billion-dollar budgets. Today, Sphinx helps pharmacies strengthen operations, data strategy and long-term growth in an increasingly complex market.
Key Takeaways
- The infusion and specialty pharmacy market has rapidly evolved, increasing pressure on independent providers to adapt and differentiate.
- Clear value propositions and niche focus are essential as pharmacies face closures and tighter margins.
- Integrated operations, clinical expertise and data strategy are critical for long-term success and must be driven by leadership.
- Strong data and disease-state expertise improve access to manufacturers, especially as new cell and gene therapies come to market.
- Pharmacies should optimize and leverage existing data and workflows before expanding services or sites of care.
- Site-of-care strategies must align with patient volume, provider preferences and operational scale to be successful.
At its core, this episode highlights a clear message: sustainable growth in infusion pharmacy comes from operational excellence, smart data strategy and focused differentiation. Vic explains that Sphinx Strategies partners with pharmacies to identify missing puzzle pieces, whether that’s strategy, valuation, due diligence or long-term planning, so they can stay competitive and build lasting ROI.
Don’t miss this final Beyond the Drip episode of the year for a discussion on where infusion pharmacy is headed and how independent providers can position themselves for the future. Tune in now!
---
Vic Simianu, Founder & CEO of Sphinx Strategies
Vic Simianu is the Founder and CEO of Sphinx Strategies, a consulting group focused on building highly integrated specialty pharmacy operations. One of the industry’s earliest ACHC-Certified Specialty Pharmacy Consultants, Vic brings deep expertise in accreditation strategy, operational excellence, and oncology-focused specialty services. His experience spans independent pharmacies, large IDNs, ACOs, and publicly traded organizations. Vic holds an MBA from Indiana University Kelley School of Business and leads Sphinx Strategies from Boulder, Colorado.
Beyond the Drip Co-hosts:
Paula Roth, VP of Pharmacy Services at Prochant
As Vice President of Pharmacy Operations at Prochant, Paula leads an expert team focused on enhancing the home-based care industry through innovative technology and streamlined processes. With more than 20 years of experience in revenue cycle management for alternate sites of care, Paula leverages technology and teams to ensure clients achieve or exceed their financial targets.
Jon Love, President & Chief Growth...
